Targeting apoptosis in cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Apoptosis, or programmed cell death, is a key goal in cancer therapy.
• Multiple intrinsic and extrinsic signaling pathways regulate apoptosis, influenced by cellular stress, DNA damage, and immune surveillance.
• Interactions between apoptosis and other signaling pathways impact cell death outcomes.

Purpose of the Study:

• To review the main apoptosis pathways and their interactions with other signaling mechanisms.
• To discuss actionable molecular targets for pro-apoptotic therapies.
• To examine therapeutic agents in clinical translation and known resistance mechanisms.

Main Methods:

• Review of existing literature on apoptosis signaling pathways.
• Analysis of drug discovery studies for pro-apoptotic agents.
• Examination of tumor biology, including heterogeneity and resistance evolution.

Main Results:

• Apoptosis pathways are complex, involving intrinsic and extrinsic signaling cascades.
• Clinical translation of pro-apoptotic agents requires addressing drug properties and tumor biology.
• Tumor resistance to apoptosis can lead to therapeutic failure and patient mortality.

Conclusions:

• Understanding apoptosis pathways and their interactions is vital for developing effective cancer therapies.
• Targeting apoptosis offers a promising strategy, but overcoming resistance is critical.
• Further research into molecular targets and resistance mechanisms will advance clinical oncology.